Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020936 · ClinicalTrials.gov registry record · NA
AIDANET Pediatrics
A NA study of Type 1 Diabetes, sponsored by Mark D. DeBoer, MD, MSc., MCR.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 3
- Study locations
NCT07020936: Recruiting NA study of Type 1 Diabetes, sponsored by Mark D. DeBoer, MD, MSc., MCR.
NCT07020936 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Mark D. DeBoer, MD, MSc., MCR. The registered enrollment target is 36 participants, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07020936, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Mark D. DeBoer, MD, MSc., MCR.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 3
- Study locations
Study Summary
AIDANET algorithm with smart-phone based control system (study smart phone), specifically modified Tandem insulin system (study insulin pump), and Dexcom G6 CGM (study CGM).
Primary Outcome
Non-inferiority of the mean CGM between the two weeks of the Usual Care observational period and the two weeks of AIDANET at-home
Conditions Studied
Interventions
- DEVICE Normal Glycemia Goal
- DEVICE Tight Glycemia Goal
Study Locations (3)
California
- University of California San Francisco - San Francisco
Colorado
- Barbara Davis Center, University of Colorado - Aurora
Virginia
- University of Virginia Center for Diabetes Technology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-07-21 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT07020936 shows while recruiting
NCT07020936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 767-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Normal Glycemia Goal is the first listed.
NCT07020936 reports a single indexed study location in California, Colorado, Virginia.
Frequently Asked Questions
What is clinical trial NCT07020936 about?
NCT07020936 is a clinical study titled "AIDANET Pediatrics". AIDANET algorithm with smart-phone based control system (study smart phone), specifically modified Tandem insulin system (study insulin pump), and Dexcom G6 CGM (study CGM).
What is the current status of trial NCT07020936?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-07-21. Estimated completion is 2026-03-30.
What conditions does trial NCT07020936 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT07020936?
The interventions under investigation include: Normal Glycemia Goal (DEVICE), Tight Glycemia Goal (DEVICE).
Who is sponsoring clinical trial NCT07020936?
This trial is sponsored by Mark D. DeBoer, MD, MSc., MCR, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020936 being conducted?
This trial has 3 study locations across California, Colorado, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07020936's enrollment target sits among peer trials
36 114th of 198 higher than 83 of 198 other Type 1 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
-
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI